Interpretation of a new biomarker for the right ventricle introduced to evaluate the severity of pulmonary arterial hypertension

Pulm Circ. 2019 Apr-Jun;9(2):2045894019826945. doi: 10.1177/2045894019826945.

Peter L M Kerkhof¹, John K-J Li^{2

3}, Neal Handly⁴

¹ 1 Amsterdam Cardiovascular Sciences, Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.
² 2 Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, USA.
³ 3 College of Biomedical Engineering, Zhejiang University, Hangzhou, China.
⁴ 4 Department of Emergency Medicine, Drexel University College of Medicine, Philadelphia PA, USA.

No abstract available

Keywords: biomarker; pediatric cardiology; pulmonary arterial hypertension; right ventricle; risk stratification.